TRIM59 and pachyonychia congenita: Next, to assess the implied application value of targeting TRIM59 as an effective method for treating PC, a structure-based virtual screening of nearly 3000 compounds was performed using the FDA library to identify potential TRIM59 inhibitors (Fig. 7A).